Samsung Pharm (001360) — Cash Flow Reinvestment Rate
Samsung Pharm (001360) has a Cash Flow Reinvestment Rate of 0.48x as of June 2022, reinvesting ₩766.26 Million (capex ₩638.30 Million plus investments ₩-127.95 Million) from operating cash flow of ₩1.59 Billion. Check Samsung Pharm earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samsung Pharm Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Samsung Pharm across 1 annual periods. Explore Samsung Pharm long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Samsung Pharm (2017–2017)
Year-by-year capital reinvestment analysis for Samsung Pharm. For live market cap and broader valuation context, see 001360 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.26x | ₩6.51 Billion | ₩5.15 Billion | ₩6.11 Billion | — |